5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br...oad short-term and long-term solutions to address and alleviate supply shortages related to vaccine products with non-standard dose volumes.
more
Brazilian media and science communicators must understand the main characteristics of misinformation in social media about COVID-19, so that they can develop attractive, up-to-date and evidence-based content that helps to increase health literacy and counteract the spread of false information.
Existe mucha información circulando alrededor del
coronavirus, pero no toda es verdad.
Es importante estar bien informados para así poder protegernos y proteger a nuestras comunidades
Este folleto informativo acerca del coronavirus (COVID-19), está elaborado especialmente para ti que estás a cargo del cuidado de un niño o adolescente con alguna enfermedad oncológica o hematológica. 1 Al tener un sistema de defensas debilitad...o por el tratamiento y enfermedad, ellos se encuentran más expuestos a las complicaciones que trae este virus y comprendemos que como madre, padre o cuidador, puedes tener muchas preguntas al respecto y es importante que cuentes con información adecuada que te permita saber qué hacer y cómo acompañar al menor a cargo en esta especial situación.
more
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In thi...s edition, new information includes updated mask recommendations for children in community settings including updated age specific recommendations, statements for children with disabilities and those at high risk for complications related to COVID-19 infection. Updated implementation considerations for mask use in school settings are also included.
This living guideline is being published using the MAGICApp online publishing platform https://app.magicapp.org/#/guideline/Lr2a8L , as well as in PDF copy on the WHO website.
more
Action plan for preventive measures to avoid coronavirus infection COVID-19
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc...ern including Omicron. Masks continue to be a critical tool to prevent the spread of COVID-19. These interim guidelines supersede the recommendations provided in the WHO recommendations on mask use by health workers, in light of the Omicron variant of concern published on 22 December 2022.
WHO continually evaluates the emerging evidence and will review these interim recommendations within two months and issue new guidance as needed.
more
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given ...that a vaccine will eventually be produced, information will be needed to support a potential campaign to promote vaccination.
Objective: The aim of this study was to determine the variables affecting the likelihood of refusal and indecision toward a vaccine against COVID-19 and to determine the acceptance of the vaccine for different scenarios of effectiveness and side effects.
Materials and Methods: A multinomial logistic regression method based on the Health Belief Model was used to estimate the current methodology, using data obtained by an online anonymous survey of 370 respondents in Chile.
Results: The results indicate that 49% of respondents were willing to be vaccinated, with 28% undecided or 77% of individuals who would potentially be willing to be inoculated. The main variables that explained the probability of rejection or indecision were associated with the severity of COVID-19, such as, the side effects and effectiveness of the vaccine; perceived benefits, including immunity, decreased fear of contagion, and the protection of oneself and the environment; action signals, such as, responses from ones' family and the government, available information, and specialists' recommendations; and susceptibility, including the contagion rate per 1,000 inhabitants and relatives with COVID-19, among others. Our analysis of hypothetical vaccine scenarios revealed that individuals preferred less risky vaccines in terms of fewer side effects, rather than effectiveness. Additionally, the variables that explained the indecision toward or rejection of a potential COVID-19 vaccine could be used in designing public health policies.
Conclusions: We discovered that it is necessary to formulate specific, differentiated vaccination-promotion strategies for the anti-vaccine and undecided groups based on the factors that explain the probability of individuals refusing or expressing hesitation toward vaccination.
more
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...placing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
more
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection ...prevention and control (IPC). This living guideline is available both online and PDF.
**This version of the living guideline (version 5.0) **includes the following seven revised statements for the prevention, identification and management of SARS-CoV-2 infections among health and care workers:
a good practice statement on national and subnational testing strategies;
a good practice statement on passive syndromic surveillance of health and care workers;
a good practice statement on prioritizing health and care workers for SARS-CoV-2 testing;
a good practice statement on protocols for reporting and managing health and care worker exposures;
a good practice statement to limit in-person work of health and care workers with active SARS-CoV-2 infections;
a statement on high-risk exposures and quarantine; and,
a conditional recommendation on the duration of isolation for health and care workers.
Understanding the updated section
Prevention of infections in the health care setting includes a multi-pronged and multi-factorial approach that includes IPC and occupational health and safety measures and adherence to Public Health and Social Measures in the community by the health workforce. The underlying infection prevention and control strategy of this section is the notion that early identification of symptomatic cases, testing and quarantining/isolating health and care workers decreases the risk of nosocomial infection to patients and to other health and care workers.
more
Cardiovascular disease, heart disease, and coronary heart disease may sound similar but they are not one in the same. This fact sheet will help you understand how these conditions differ.
This page presents all our content related to COVID-19. It aims to: 1. Help people who want to understand or work on COVID-19 right now. 2. Help people who are considering biosecurity careers longer term.
This page will focus on leveraged opportunities in research, policy, technology and startups. ...Many people will find their best opportunities to help in their local community – supporting health workers, driving delivery vans, helping friends and family, looking after neighbours, and so on. If you already play a role in providing essential services it’s likely that working hard at your day job, while making efforts to avoid spreading the virus, is one of the most valuable things you can do.
more
Malattie infettive come il COVID-19 possono implicare una interruzione delle attività negli ambienti in cui i bambini crescono e si sviluppano. Tali interruzioni, che coinvolgono famiglie, amicizie, routine quotidiane e la comunità nel suo senso più ampio, possono avere conseguenze negative sul b...enessere, lo sviluppo e la protezione dei bambini.
more
Enfermedades infecciosas como el COVID-19 pueden alterar los entornos donde niños, niñas y adolescentes crecen y se desarrollan. Cambios que desestabilizan a la familia, las amistades, la rutina diaria y la comunidad en general o pueden tener consecuencias negativas en el bienestar, el desarrollo ...y la protección de la niñez y adolescencia. Además, las mismas medidas emprendidas para prevenir y controlar la transmisión del COVID-19 pueden conllevar riesgos de protección en niños, niñas y adolescentes. Las medidas de cuarentena y aislamiento en el hogar, las instalaciones o zonas concretas pueden afectar negativamente a los niños, las niñas y sus familias.
Este documento aspira a brindar apoyo a los profesionales de la protección de la niñez y adolescencia para que puedan responder de manera más eficiente a los riesgos de protección durante la pandemia del COVID-19. En la 1ª Parte se presentan los posibles riesgos en materia de protección de la niñez y adolescencia que puede generar el COVID-19, mientras que en la 2ª Parte se ofrecen opciones programáticas que se adhieren a las normas mínimas para la protección de la niñez y adolescencia en la acción humanitaria (NMPI o CPMS, por sus siglas en inglés) de 2019 y la nota orientativa sobre la protección de la niñez y adolescencia durante brotes de enfermedades infecciosas (enlaces en inglés).
more
Les maladies infectieuses comme le COVID-19 peuvent perturber l’environnement dans lequel les enfants grandissent et se développent. Les bouleversements qui affectent les familles, les relations avec les amis, les routines quotidiennes et l’ensemble de la communauté peuvent avoir des répercus...sions négatives sur le bien-être, le développement et la protection des enfants. En outre, les mesures appliquées pour prévenir et contrôler la propagation du COVID-19 peuvent exposer les enfants à des risques pour leur protection. Les mesures de quarantaine et d’isolement au domicile ainsi que dans des installations ou des zones spécifiques peuvent affecter de façon négative les enfants et leur famille.
L’objectif du présent document est d’aider les professionnels de la protection de l’enfance à mieux faire face aux risques dans ce domaine lors d’une pandémie de COVID-19. La première partie présente les risques potentiels pour la protection de l’enfance auxquels le COVID-19 peut exposer les enfants. La seconde partie décrit des options programmatiques conformes à l’édition 2019 des Standards minimum de protection de l’enfance dans l’action humanitaire (SMPE) et à la Note d’information : Protection des enfants lors d’épidémies de maladies infectieuses (en anglais).
more